Molbio Diagnostics Gains on Market Debut
· Business · Business Standard
Molbio Diagnostics made a positive debut on the stock market, reflecting strong investor interest in the healthcare sector. The company's shares listed at a premium over their issue price. The report does not specify the exact listing gains or the total issue size. Molbio Diagnostics specializes in molecular diagnostic systems and medical devices. Further details regarding the trading volume were not immediately available.
Why it matters
The successful listing provides liquidity to early investors and signals ongoing market appetite for Indian healthcare and diagnostics companies.
Read the original report — Business Standard
Join us on Telegram
Breaking news the moment it lands. At 10,000 members we ship the Android app.